KnowraRituximabLinked fromLinked fromThe 19 pages that link to Rituximab, each with the reason it gives.All 19Broader topic 4Related 11Compared with 4B cellRelated: It treats some B-cell cancers and autoimmune diseases by depleting CD20-positive cells.VasculitisRelated: It is used to treat certain severe or relapsing vasculitis syndromes.Granulomatosis with polyangiitisRelated: It is used with glucocorticoids to induce or maintain remission in many patients.Thrombotic thrombocytopenic purpuraRelated: It can suppress anti-ADAMTS13 autoantibodies and reduce relapse risk.Autoimmune hemolytic anemiaRelated: It can treat autoimmune hemolytic anemia that persists or returns after initial therapy.Microscopic polyangiitisRelated: It is an induction and maintenance option for many patients with severe ANCA-associated vasculitis.Chronic inflammatory demyelinating polyneuropathyRelated: It may be considered in selected difficult cases, especially when nodal antibodies are found.Neuromyelitis optica spectrum disorderRelated: B-cell depletion is used to reduce relapses and antibody-driven inflammation.Castleman diseaseRelated: It is used in some HHV-8-associated cases to reduce infected B cells.Stiff-person syndromeRelated: It has been tried as immune-directed therapy, but benefits in stiff-person syndrome are inconsistent.Anti-NMDA receptor encephalitisRelated: It is used as second-line immunotherapy when initial treatment does not control the disease.